PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

Core Insights - PetVivo Holdings, Inc. has entered into a distribution agreement with Eq Especialidades to market its veterinary medical device, Spryng with OsteoCushion technology, in Mexico, starting April 1, 2025 [1][3] - Spryng with OsteoCushion technology is designed to manage joint pain in animals by promoting proper joint mechanics and integrating with subsynovial tissue [2][6] - The partnership with Eq Especialidades is expected to enhance PetVivo's market presence in the Mexican animal health sector, benefiting veterinarians and pet owners alike [3] Company Overview - PetVivo Holdings, Inc. focuses on the commercialization of innovative medical devices and therapeutics for companion animals, leveraging human therapies for efficient treatment [5] - The company has a portfolio of 21 patents protecting its biomaterials and products, with lead products including Spryng and PrecisePRP available for commercial sale [6]